Trial Profile
A Phase I, Open-Label, Randomized, 2-Way Crossover Trial in 40 Healthy Subjects to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-State.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Dec 2010
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Darunavir; Fosamprenavir; Ritonavir
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 16 Dec 2010 Actual initiation date changed from May 2008 to Jun 2008 as reported by ClinicalTrials.gov.
- 06 Nov 2008 New trial record.